Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04002973 · ClinicalTrials.gov registry record · NA
Desaturation Validation of INVSENSOR00037
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT04002973 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 11 participants.
The verdict
NCT04002973, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study is designed to evaluate the trending accuracy of a noninvasive regional oximetry measurement of somatic oxygen saturation. One investigational sensor (INVSENSOR00037) will be placed on the somatic site of the volunteer. The values obtained by the test sensor will be compared to the reference value obtained from an FDA-cleared sensor placed on the somatic site on the contralateral side.
Interventions
- DEVICE INVSENSOR00037
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-06-21 |
| Est. Completion | 2019-06-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04002973
The ClinicalTrials.gov registry entry for NCT04002973 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which INVSENSOR00037 is the first listed.
NCT04002973 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04002973 about?
NCT04002973 is a clinical study titled "Desaturation Validation of INVSENSOR00037". This study is designed to evaluate the trending accuracy of a noninvasive regional oximetry measurement of somatic oxygen saturation. One investigational sensor (INVSENSOR00037) will be placed on the somatic site of the volunteer. The values obtained by the test sensor will be compared to the refere...
What is the current status of trial NCT04002973?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2019-06-21. Estimated completion is 2019-06-28.
What interventions are being tested in trial NCT04002973?
The interventions under investigation include: INVSENSOR00037 (DEVICE).
Who is sponsoring clinical trial NCT04002973?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.